REPL(Replimune Group, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-16 | Xynos Konstantinos | Chief Medical Officer | 公开市场卖出 | 16,198 | $21.60 |
| 2026-11-16 | Schwendenman Andrew | Chief Accounting Officer | 公开市场卖出 | 2,148 | $21.60 |
| 2026-11-16 | Patel Sushil | Chief Executive Officer | 公开市场卖出 | 49,026 | $21.60 |
| 2026-11-16 | Hill Emily Luisa | Chief Financial Officer | 公开市场卖出 | 14,709 | $21.60 |
| 2026-11-09 | SLATTERY JOSEPH P | 董事 | 公开市场卖出 | 5,200 | $21.80 |
| 2026-11-02 | Dhingra Kapil | 董事 | 公开市场卖出 | 21,500 | $19.00 |
| 2026-08-17 | Hill Emily Luisa | Chief Financial Officer | 公开市场卖出 | 9,256 | $14.28 |
| 2026-08-11 | BAKER BROS. ADVISORS LP | 董事、10% 股东 | 公开市场买入 | 2,609,946 | $12.06 |
| 2026-08-11 | BAKER BROS. ADVISORS LP | 董事、10% 股东 | 公开市场买入 | 126,394 | $12.06 |
| 2026-08-10 | Patel Sushil | Chief Executive Officer | 公开市场卖出 | 39,341 | $12.97 |
| 2026-08-10 | Hill Emily Luisa | Chief Financial Officer | 公开市场卖出 | 11,448 | $12.97 |
| 2026-08-10 | Xynos Konstantinos | Chief Medical Officer | 公开市场卖出 | 11,447 | $12.97 |
| 2026-08-10 | Schwendenman Andrew | Chief Accounting Officer | 公开市场卖出 | 7,632 | $12.97 |
| 2026-06-01 | Sarchi Christopher | Chief Commercial Officer | 公开市场卖出 | 12,000 | $9.24 |
| 2026-05-18 | Xynos Konstantinos | Chief Medical Officer | 公开市场卖出 | 14,023 | $5.08 |
| 2026-05-18 | Schwendenman Andrew | Chief Accounting Officer | 公开市场卖出 | 7,894 | $5.08 |
| 2026-05-18 | Sarchi Christopher | Chief Commercial Officer | 公开市场卖出 | 8,626 | $5.08 |
| 2026-05-18 | Astley-Sparke Philip | 董事 | 公开市场卖出 | 17,657 | $5.08 |
| 2026-05-18 | Patel Sushil | Chief Executive Officer | 公开市场卖出 | 37,324 | $5.08 |
| 2026-05-18 | Hill Emily Luisa | Chief Financial Officer | 公开市场卖出 | 7,812 | $5.08 |